Michael A. Metzger

CEO

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

SNDX

Current role

CEO, Board Member

2026-06-10–present

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Syndax Pharmaceuticals Inc (SNDX)	Chief Executive Officer	$754,300	—	$2,021,965	$3,454,360	$848,588	$10,000	$7,089,213
2024	Syndax Pharmaceuticals Inc (SNDX)	Chief Executive Officer	$715,000	—	$3,258,450	$3,208,211	$515,515	$10,000	$7,707,176
2023	Syndax Pharmaceuticals Inc (SNDX)	Chief Executive Officer	$678,400	—	—	$8,023,803	$417,216	$8,000	$9,127,419
2022	Syndax Pharmaceuticals Inc (SNDX)	Chief Executive Officer	$640,000	—	—	$3,062,276	$403,200	$8,000	$4,113,476
2021	Syndax Pharmaceuticals Inc (SNDX)	Chief Executive Officer	$594,104	—	—	$2,434,751	$297,050	$8,000	$3,333,905
2020	Syndax Pharmaceuticals Inc (SNDX)	Chief Executive Officer	$576,800	—	$142,050	$950,701	$273,980	$6,000	$1,949,531

No earnings-call appearances or filed executive changes recorded yet.